Multifocal motor neuropathy (MMN): treatment
Evidence-based neurology checklist on multifocal motor neuropathy (mmn): treatment: Intravenous immunoglobulins (IVIg) The starting dose is 2g/kg over 2-5 days The maintenance dose is 1g/kg 2-4 weekly or 2g/kg 4-8 weekly The response rate is 94% Potential agents Predictors of treatment response
Intravenous immunoglobulins (IVIg)
- The starting dose is 2g/kg over 2-5 days
- The maintenance dose is 1g/kg 2-4 weekly or 2g/kg 4-8 weekly
- The response rate is 94%
Potential agents
Predictors of treatment response
References
- van der Pol W-L, Cats EA, van den Berg LH. Intravenous immunoglobulin treatment in multifocal motor neuropathy. J Clin Immunol 2010; 30 (Suppl 1):S79-S83.
- van Schaik IN, Bouche P, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 2006; 13:802-808.
- Katz JS, Barohn RJ, Kojan S, et al. Axonal multifocal motor neuropathy without conduction block or other features of determination. Neurology 2002; 58:615-620.
- Cats EA, vsn der Pol W-L, Piepers S, et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 2010; 75:818-825.
- Van Asseldonk JT, Franssen H, Van den Berg-Vos RM, Wokke JH, Van den Berg LH. Multifocal motor neuropathy. Lancet Neurol 2005; 4:309-319.
- And 5 more. Subscribe to see the full list
